Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis

NCT00728507 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

121

Enrollment

OTHER

Sponsor class

Stopped Funding withdrawn

Conditions

Tuberculosis

Interventions

DRUG: Rifapentine, Moxifloxacin, Pyrazinamide, Isoniazid
DRUG: Isoniazid, Rifampin, Pyrazinamide, Ethambutol

Sponsor

Johns Hopkins University

Collaborators

[object Object]